Form 4 for CRL Charles River Laboratories
Accepted 2026-05-14 17:11:40 ET · period of report 2026-05-12 · accession 0001100682-26-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 17:11 | 2026-05-12 | CRL | Andrews Nancy C | Dir | G - Gift | $0.00 | -3,964 | 1,438 | -73% | $0 | |
| I | 2026-05-14 17:11 | 2026-05-12 | CRL | Andrews Nancy C | Dir | G - Gift | $0.00 | +3,964 | 3,964 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-12 | G | D | 3,964 | $0.00 | 1,438 | D | — | — | (F1) Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person. |
| 2 | Common | Common Stock | 2026-05-12 | G | A | 3,964 | $0.00 | 3,964 | I By Trust | — | — | (F1) Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person. |